@Squeaks
1) Is this possible? let's take a look. Reports suggest this $120m cost base will work it's way down to NPAT, unlike the typical "controllable cost".
Take a conservative view with $200m npat for FY25 + $120m cost base reduction, $320m
With the remaining $70m BB lets say current shares on issue get to 2.75b, We get a price around $1.85
2) Let's say the BOLR case blows out 200% & SH CA $50m, only $100m of the 3rd tranche goes towards the BB - $1.93
3) BOLR case blows out 50% & SH CA $25m, only $200m of that 3rd tranche hits the BB - $1.96
You see where its going if the BOLR case goes over by a little ($10m or $20m) or none and the SH class action goes AMP's way. It attracts a $2 tag.
If advice breaks even by 24, it may be making a few nickels by 25 we could add to the scenarios.
Off course it all hinges on that cost base reduction.
AMP Price at posting:
$1.25 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)